+Follow
Leonardk
No personal profile
2
Follow
6
Followers
0
Topic
0
Badge
Posts
Hot
Leonardk
2021-08-01
Please like
Expect More Underwhelming Performance for SoFi Shares
Leonardk
2021-07-29
Do we hold?
AMD Is The New Bellwether
Leonardk
2021-06-29
Up up up
Do Cannabis Stocks Need Tax Reform More Than Legalization?
Leonardk
2021-06-19
Hang in there
3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3582686134372532","uuid":"3582686134372532","gmtCreate":1619592110310,"gmtModify":1706620740423,"name":"Leonardk","pinyin":"leonardk","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/676f5d832122882228ccbdd0362da858","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":2,"tweetSize":4,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.24","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.44%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.66%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":802478837,"gmtCreate":1627800653029,"gmtModify":1703496089105,"author":{"id":"3582686134372532","authorId":"3582686134372532","name":"Leonardk","avatar":"https://static.tigerbbs.com/676f5d832122882228ccbdd0362da858","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582686134372532","authorIdStr":"3582686134372532"},"themes":[],"htmlText":"Please like","listText":"Please like","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/802478837","repostId":"1147877145","repostType":4,"repost":{"id":"1147877145","pubTimestamp":1627784916,"share":"https://ttm.financial/m/news/1147877145?lang=&edition=fundamental","pubTime":"2021-08-01 10:28","market":"us","language":"en","title":"Expect More Underwhelming Performance for SoFi Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1147877145","media":"InvestorPlace","summary":"The odds of a rapid rebound for fintech play SOFI stock appear dim.\n\nAsSoFiTechnologies(NASDAQ:SOFI)","content":"<blockquote>\n <b>The odds of a rapid rebound for fintech play SOFI stock appear dim.</b>\n</blockquote>\n<p>As<b>SoFiTechnologies</b>(NASDAQ:<b><u>SOFI</u></b>) stock falls back to around $15 per share, is now the time to buy? Not really. Over a long enough timeframe, entering a position in the fintech company’s shares right now could end up being a highly profitable move.</p>\n<p>Assuming of course, that it becomes the next<b>PayPal</b>(NASDAQ:<b><u>PYPL</u></b>) or<b>Square</b>(NYSE:<b><u>SQ</u></b>). Even so, that doesn’t mean there’s an urgent need to rush out and buy it today. More likely than not, the stock will deliver underwhelming returns in the months ahead.</p>\n<p>Why? The negative factors that have been weighing down on growth stocks. First, the risk that a hike in interest rates will result in avaluation contraction for richly priced namessuch as this one. Second, slowing economic growth could be another risk for shares. If today’s booming economy takes a breather, it may be tough for SoFi to deliver the blockbuster quarterly results investors expect from it.</p>\n<p>With the possibility of it languishing at $15 per share. Or worse yet, falling to $10 per share or less, the best move hasn’t changed in the past month. If you’re still bullish on it? Take your time when it comes to entering a position.</p>\n<p><b>SOFI Stock and Possible Further Downside</b></p>\n<p>After itsJune 1 deSPACing, SoFi shares seemed primed to make a comeback. Not only that, it seemed like the reputation of Chamath Palihapitiya, the sponsor of this former SPAC (special purpose acquisition company) was making a comeback as well.</p>\n<p>Yet, flash-forward around two months, and it seems like things are getting to where they were after last spring’s“SPAC Wipeout.”Investors haven’t shown much interest in Palihapitiya’slatest SPAC venture has been met with a yawn. Shares in his higher-profile holdings, like SOFI stock, along with<b>Clover Health</b>(NASDAQ:<b><u>CLOV</u></b>) stock have again lost their luster as well.</p>\n<p>SoFi has fallen back once again. But don’t assume it’s bottomed out. Not as much to do with any issues with the company itself. Instead, due to economy-wide factors that may result in it making another move to lower price levels. Again, as I’ve discussed previously, rising interest rates could have a big negative impact on its share price. Even as rising rates will be good for the company’s lending operations, this could be more than countered by valuation contraction.</p>\n<p>Giving things another look, it’s clear there’s another risk factor that could knock down the stock once again. That’s the potential for economic growth to start slowing down.</p>\n<p><b>High Valuation</b></p>\n<p>SOFI stock may be down big from its all-time high. But at today’s levels, it remains a “priced for perfection” situation. With projections calling for high double-digit growth, and recent results pointing to itbeating guidance, investors continue to have no trouble giving this stock a rich valuation.</p>\n<p>At $15 per share, shares trade for around 8.4x estimated 2022 revenues. Some, including<i>InvestorPlace’s</i>Larry Ramer, have questioned whether it makes sense to value this companymore like a tech firm than a bank. I also see this as an area of concern. Yet I don’t expect this factor alone to be what knocks it down to lower prices.</p>\n<p>What will? Again, it’s a sooner-than-expected rise in interest rates that could send shares down to even lower prices. But that’s not the only thing that could do so. Even if the Federal Reserve doesn’t turn on a dime, and shift from dovish to hawkish monetary policy, SOFI stock could find itself in trouble. How? If it starts delivering disappointing quarterly results.</p>\n<p>Sure, this may not happen in the immediate future. Yet, the above-average economic growth seen during the pandemic recovery/reopeningcould be running out of gas. If the economy starts to slow? It may get tougher for SoFi to live up to the high expectations currently priced into shares. Along with the valuation contraction risk, this is something else that could it down before it starts to rally once again.</p>\n<p><b>No Rush to Dive in at Today’s Prices</b></p>\n<p>Now may seem like an opportune time to scoop up SoFi shares on the cheap. But after selling off again, I wouldn’t expect any sort of rapid recovery. Just like a few weeks back, the risk of valuation contraction runs high. As more comes out of today’s still-booming economy could be set to slow down? The risk of underwhelming results in future quarters is starting to loom as well.</p>\n<p>So, with more negatives than positives, SOFI stock is likely to either going to trade sideways in the short term or worse, head down to lower prices. With this in mind, even investors who believe it’s a long-term winner shouldn’t hastily dive into it.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Expect More Underwhelming Performance for SoFi Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nExpect More Underwhelming Performance for SoFi Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-01 10:28 GMT+8 <a href=https://investorplace.com/2021/07/sofi-stock-expect-continued-underwhelming-performance/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The odds of a rapid rebound for fintech play SOFI stock appear dim.\n\nAsSoFiTechnologies(NASDAQ:SOFI) stock falls back to around $15 per share, is now the time to buy? Not really. Over a long enough ...</p>\n\n<a href=\"https://investorplace.com/2021/07/sofi-stock-expect-continued-underwhelming-performance/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SOFI":"SoFi Technologies Inc."},"source_url":"https://investorplace.com/2021/07/sofi-stock-expect-continued-underwhelming-performance/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147877145","content_text":"The odds of a rapid rebound for fintech play SOFI stock appear dim.\n\nAsSoFiTechnologies(NASDAQ:SOFI) stock falls back to around $15 per share, is now the time to buy? Not really. Over a long enough timeframe, entering a position in the fintech company’s shares right now could end up being a highly profitable move.\nAssuming of course, that it becomes the nextPayPal(NASDAQ:PYPL) orSquare(NYSE:SQ). Even so, that doesn’t mean there’s an urgent need to rush out and buy it today. More likely than not, the stock will deliver underwhelming returns in the months ahead.\nWhy? The negative factors that have been weighing down on growth stocks. First, the risk that a hike in interest rates will result in avaluation contraction for richly priced namessuch as this one. Second, slowing economic growth could be another risk for shares. If today’s booming economy takes a breather, it may be tough for SoFi to deliver the blockbuster quarterly results investors expect from it.\nWith the possibility of it languishing at $15 per share. Or worse yet, falling to $10 per share or less, the best move hasn’t changed in the past month. If you’re still bullish on it? Take your time when it comes to entering a position.\nSOFI Stock and Possible Further Downside\nAfter itsJune 1 deSPACing, SoFi shares seemed primed to make a comeback. Not only that, it seemed like the reputation of Chamath Palihapitiya, the sponsor of this former SPAC (special purpose acquisition company) was making a comeback as well.\nYet, flash-forward around two months, and it seems like things are getting to where they were after last spring’s“SPAC Wipeout.”Investors haven’t shown much interest in Palihapitiya’slatest SPAC venture has been met with a yawn. Shares in his higher-profile holdings, like SOFI stock, along withClover Health(NASDAQ:CLOV) stock have again lost their luster as well.\nSoFi has fallen back once again. But don’t assume it’s bottomed out. Not as much to do with any issues with the company itself. Instead, due to economy-wide factors that may result in it making another move to lower price levels. Again, as I’ve discussed previously, rising interest rates could have a big negative impact on its share price. Even as rising rates will be good for the company’s lending operations, this could be more than countered by valuation contraction.\nGiving things another look, it’s clear there’s another risk factor that could knock down the stock once again. That’s the potential for economic growth to start slowing down.\nHigh Valuation\nSOFI stock may be down big from its all-time high. But at today’s levels, it remains a “priced for perfection” situation. With projections calling for high double-digit growth, and recent results pointing to itbeating guidance, investors continue to have no trouble giving this stock a rich valuation.\nAt $15 per share, shares trade for around 8.4x estimated 2022 revenues. Some, includingInvestorPlace’sLarry Ramer, have questioned whether it makes sense to value this companymore like a tech firm than a bank. I also see this as an area of concern. Yet I don’t expect this factor alone to be what knocks it down to lower prices.\nWhat will? Again, it’s a sooner-than-expected rise in interest rates that could send shares down to even lower prices. But that’s not the only thing that could do so. Even if the Federal Reserve doesn’t turn on a dime, and shift from dovish to hawkish monetary policy, SOFI stock could find itself in trouble. How? If it starts delivering disappointing quarterly results.\nSure, this may not happen in the immediate future. Yet, the above-average economic growth seen during the pandemic recovery/reopeningcould be running out of gas. If the economy starts to slow? It may get tougher for SoFi to live up to the high expectations currently priced into shares. Along with the valuation contraction risk, this is something else that could it down before it starts to rally once again.\nNo Rush to Dive in at Today’s Prices\nNow may seem like an opportune time to scoop up SoFi shares on the cheap. But after selling off again, I wouldn’t expect any sort of rapid recovery. Just like a few weeks back, the risk of valuation contraction runs high. As more comes out of today’s still-booming economy could be set to slow down? The risk of underwhelming results in future quarters is starting to loom as well.\nSo, with more negatives than positives, SOFI stock is likely to either going to trade sideways in the short term or worse, head down to lower prices. With this in mind, even investors who believe it’s a long-term winner shouldn’t hastily dive into it.","news_type":1},"isVote":1,"tweetType":1,"viewCount":703,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":808363693,"gmtCreate":1627558001912,"gmtModify":1703492329751,"author":{"id":"3582686134372532","authorId":"3582686134372532","name":"Leonardk","avatar":"https://static.tigerbbs.com/676f5d832122882228ccbdd0362da858","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582686134372532","authorIdStr":"3582686134372532"},"themes":[],"htmlText":"Do we hold?","listText":"Do we hold?","text":"Do we hold?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/808363693","repostId":"1131779285","repostType":4,"repost":{"id":"1131779285","pubTimestamp":1627551074,"share":"https://ttm.financial/m/news/1131779285?lang=&edition=fundamental","pubTime":"2021-07-29 17:31","market":"us","language":"en","title":"AMD Is The New Bellwether","url":"https://stock-news.laohu8.com/highlight/detail?id=1131779285","media":"seekingalpha","summary":"Summary\n\nAMD's earnings report on Tuesday has pushed me over the edge as to where my money needs to ","content":"<p><b>Summary</b></p>\n<ul>\n <li>AMD's earnings report on Tuesday has pushed me over the edge as to where my money needs to be.</li>\n <li>The revenue growth and valuations prove the market wants one thing: Growth.</li>\n <li>Intel has lost the bellwether title as it grows below the industry and AMD grows above it.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8a41ea3a1a9c98364332ee70330427e8\" tg-width=\"1536\" tg-height=\"1024\" width=\"100%\" height=\"auto\"><span>nantonov/iStock Editorial via Getty Images</span></p>\n<p>It's hard to deny AMD (AMD) isn't the new up-and-coming bellwether of logic semiconductors, a position undoubtedly claimed by the chip king Intel (INTC). With AMD's latest earnings report on Tuesday, the title is no longer uncontested, even with the dramatic difference in absolute dollar figures between the two. One is growing big time while the other has been in a perpetual state of discord, in part or in whole, due to unresolved business direction. On Tuesday, AMD proved it isn't relenting any time soon in its pursuit of taking the semiconductor bellwether title. In fact, it may change the definition altogether as the growth it's producing in this sector is unheard of. It's time I give AMD the thumbs up and not just watch on the sidelines.</p>\n<p><b>Growth, Growth, Growth</b></p>\n<p>Much like the age-old adage for real estate of \"location, location, location\" to sell property, growth, growth, growth is the market's adage for share returns.</p>\n<p>The market is simple when it comes to tech and anything to do with it: It pays for growth, not indecision. AMD is growing, Intel is indecisive. And not just decision-making indecisive, I'm talking business execution indecisive. AMD is proving it can produce monstrous growth, and Intel is proving incremental growth is all it can do.</p>\n<p>The chart is simple. These are two very different companies:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/64f87e5b692256d2b0c4584ad37e8fdf\" tg-width=\"640\" tg-height=\"344\" width=\"100%\" height=\"auto\"><span>Chart mine, data from AMD and Intel earnings reports (non-GAAP for Intel)</span></p>\n<p>Both companies experienced a similar slowdown during the pandemic quarter of last year (Q2), but these two companies couldn't be any more different from there. While Intel struggled to find growth, especially in the data center division, AMD was stacking bills in all categories, including EPYC sales, except for a seasonal lull in semi-custom after a large gaming console launch.</p>\n<p>Since then, the story has been very dull for Intel, with flatlined or negative growth while AMD nearly doubled growth over the trough of the pandemic with its latest report.</p>\n<p>A slow down to 46%-50% in Q3 from 100% in Q2 and even from 55% to 50% year-over-year is to be expected as the great gaming console launch of 2020 will not repeat at the same level. But, to still guide for near 50% growth with that tough comp is what, in part, is driving my bullishness.</p>\n<p><b>The Valuation Proves It</b></p>\n<p>Now, of course, the market is in fact paying differently for both companies. The crucial difference is growth paves the way for better returns while stagnating growth paves the way for declines. The stock prices reflect as much:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2dad2d35040d78da964efd16dcb1a6c3\" tg-width=\"635\" tg-height=\"433\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p>\n<p>But the valuations also keep pace with the market's expectations:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bd156a2787d8c3774149c77bf71063b2\" tg-width=\"635\" tg-height=\"433\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p>\n<p><i>(AMD with Q2 and updated guidance should push the forward P/E to ~38)</i></p>\n<p>AMD's growth is worth (now) around 38 times earnings. But if you put the stock chart and the PE chart over each other, one continues to rise while the other continues to grow into it (compressing). On the other hand, Intel continues to meander as its valuation remains sideways and revenue continues to struggle, resulting in a diminishing stock return.</p>\n<p><b>The Bottom Line</b></p>\n<p>Intel bulls - you can say Intel has loads more cash flow and much higher revenue numbers (and it does), but the market isn't paying for that - clearly, as the stock price is stagnant over the last one-and-a-half years. The market is paying for growth. Period. Intel has very little to none, and AMD continues to prove it has it and more.</p>\n<p>You can be a fanboy of either company, but what good is being a fanboy if you're not getting a return on your cheerleading?</p>\n<p>One can continue to keep their money in Intel and collect 8%, including dividends, over two years, or carefully invest it in growth, which AMD is providing. This doesn't mean I love AMD's products - its graphics division leaves a lot to be desired (true ray tracing, DLSS 2.0, etc.) - but I can't stand by and hope Intel figures it out while AMD puts up the numbers it has been.</p>\n<p><b>The Bellwether Title Up For Grabs</b></p>\n<p>The basis for AMD taking over the bellwether position is because Intel can no longer provide the barometer for what the industry is doing. The semiconductor industry isn't shrinking. It's growing. From 2020 to 2021,the logic semiconductor industry is expected to grow 17% and over 6% from 2021 to 2022. Intel doesn't see that, it's below it. AMD doesn't see that, it's above it.</p>\n<p>I know which one is going to give me the heartbeat of the industry.</p>\n<p>You tell me which one is going to produce returns over the next year to two years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMD Is The New Bellwether</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMD Is The New Bellwether\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-29 17:31 GMT+8 <a href=https://seekingalpha.com/article/4442043-amd-is-the-new-bellwether><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nAMD's earnings report on Tuesday has pushed me over the edge as to where my money needs to be.\nThe revenue growth and valuations prove the market wants one thing: Growth.\nIntel has lost the ...</p>\n\n<a href=\"https://seekingalpha.com/article/4442043-amd-is-the-new-bellwether\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMD":"美国超微公司"},"source_url":"https://seekingalpha.com/article/4442043-amd-is-the-new-bellwether","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131779285","content_text":"Summary\n\nAMD's earnings report on Tuesday has pushed me over the edge as to where my money needs to be.\nThe revenue growth and valuations prove the market wants one thing: Growth.\nIntel has lost the bellwether title as it grows below the industry and AMD grows above it.\n\nnantonov/iStock Editorial via Getty Images\nIt's hard to deny AMD (AMD) isn't the new up-and-coming bellwether of logic semiconductors, a position undoubtedly claimed by the chip king Intel (INTC). With AMD's latest earnings report on Tuesday, the title is no longer uncontested, even with the dramatic difference in absolute dollar figures between the two. One is growing big time while the other has been in a perpetual state of discord, in part or in whole, due to unresolved business direction. On Tuesday, AMD proved it isn't relenting any time soon in its pursuit of taking the semiconductor bellwether title. In fact, it may change the definition altogether as the growth it's producing in this sector is unheard of. It's time I give AMD the thumbs up and not just watch on the sidelines.\nGrowth, Growth, Growth\nMuch like the age-old adage for real estate of \"location, location, location\" to sell property, growth, growth, growth is the market's adage for share returns.\nThe market is simple when it comes to tech and anything to do with it: It pays for growth, not indecision. AMD is growing, Intel is indecisive. And not just decision-making indecisive, I'm talking business execution indecisive. AMD is proving it can produce monstrous growth, and Intel is proving incremental growth is all it can do.\nThe chart is simple. These are two very different companies:\nChart mine, data from AMD and Intel earnings reports (non-GAAP for Intel)\nBoth companies experienced a similar slowdown during the pandemic quarter of last year (Q2), but these two companies couldn't be any more different from there. While Intel struggled to find growth, especially in the data center division, AMD was stacking bills in all categories, including EPYC sales, except for a seasonal lull in semi-custom after a large gaming console launch.\nSince then, the story has been very dull for Intel, with flatlined or negative growth while AMD nearly doubled growth over the trough of the pandemic with its latest report.\nA slow down to 46%-50% in Q3 from 100% in Q2 and even from 55% to 50% year-over-year is to be expected as the great gaming console launch of 2020 will not repeat at the same level. But, to still guide for near 50% growth with that tough comp is what, in part, is driving my bullishness.\nThe Valuation Proves It\nNow, of course, the market is in fact paying differently for both companies. The crucial difference is growth paves the way for better returns while stagnating growth paves the way for declines. The stock prices reflect as much:\nData by YCharts\nBut the valuations also keep pace with the market's expectations:\nData by YCharts\n(AMD with Q2 and updated guidance should push the forward P/E to ~38)\nAMD's growth is worth (now) around 38 times earnings. But if you put the stock chart and the PE chart over each other, one continues to rise while the other continues to grow into it (compressing). On the other hand, Intel continues to meander as its valuation remains sideways and revenue continues to struggle, resulting in a diminishing stock return.\nThe Bottom Line\nIntel bulls - you can say Intel has loads more cash flow and much higher revenue numbers (and it does), but the market isn't paying for that - clearly, as the stock price is stagnant over the last one-and-a-half years. The market is paying for growth. Period. Intel has very little to none, and AMD continues to prove it has it and more.\nYou can be a fanboy of either company, but what good is being a fanboy if you're not getting a return on your cheerleading?\nOne can continue to keep their money in Intel and collect 8%, including dividends, over two years, or carefully invest it in growth, which AMD is providing. This doesn't mean I love AMD's products - its graphics division leaves a lot to be desired (true ray tracing, DLSS 2.0, etc.) - but I can't stand by and hope Intel figures it out while AMD puts up the numbers it has been.\nThe Bellwether Title Up For Grabs\nThe basis for AMD taking over the bellwether position is because Intel can no longer provide the barometer for what the industry is doing. The semiconductor industry isn't shrinking. It's growing. From 2020 to 2021,the logic semiconductor industry is expected to grow 17% and over 6% from 2021 to 2022. Intel doesn't see that, it's below it. AMD doesn't see that, it's above it.\nI know which one is going to give me the heartbeat of the industry.\nYou tell me which one is going to produce returns over the next year to two years.","news_type":1},"isVote":1,"tweetType":1,"viewCount":356,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159070617,"gmtCreate":1624933264939,"gmtModify":1703848268799,"author":{"id":"3582686134372532","authorId":"3582686134372532","name":"Leonardk","avatar":"https://static.tigerbbs.com/676f5d832122882228ccbdd0362da858","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582686134372532","authorIdStr":"3582686134372532"},"themes":[],"htmlText":"Up up up","listText":"Up up up","text":"Up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/159070617","repostId":"2146831625","repostType":4,"repost":{"id":"2146831625","pubTimestamp":1624932300,"share":"https://ttm.financial/m/news/2146831625?lang=&edition=fundamental","pubTime":"2021-06-29 10:05","market":"us","language":"en","title":"Do Cannabis Stocks Need Tax Reform More Than Legalization?","url":"https://stock-news.laohu8.com/highlight/detail?id=2146831625","media":"Motley Fool","summary":"Pot companies may do better dealing with a fairer tax code than navigating a regulatory labyrinth.","content":"<p>The patchwork, state-by-state legalization of marijuana in the U.S. has created a market for cannabis companies that is less than ideal, leaving many people hoping the federal government will finally decriminalize pot, as Canada has.</p>\n<p>Yet the rollout of legal weed north of the border has also been marked by bureaucratic bungling that has inhibited cannabis stocks from realizing their full potential. Legalizing marijuana at the federal level in the U.S. might create a regulatory burden that's even more prohibitive than what legal pot companies already experience from the individual states.</p>\n<p>What the marijuana industry might need more than legalization is tax reform, because the current code is at odds with how legal cannabis businesses operate -- and with common sense.</p>\n<h2>Carrying a heavy burden</h2>\n<p>To prevent drug traffickers from profiting off their illegal activity, the federal government naturally prohibits them from taking tax deductions.</p>\n<p>While you wouldn't think that was necessary since what traffickers are doing is against the law, the tax court in the 1970s actually allowed a cocaine and amphetamines trafficker to deduct his \"business expenses,\" and Congress ended up enacting a law to prevent traffickers from doing that again.</p>\n<p>People don't consider their local marijuana dispensary owner to be anything like the guy hauling kilos of cocaine across the ocean in a cigarette boat and evading the Coast Guard. But because cannabis remains a Class I controlled dangerous substance, the Internal Revenue Service doesn't make any such distinctions.</p>\n<p>So legal cannabis companies like <b>Trulieve</b> (OTC:TCNNF) and <b>Cresco Labs</b> (OTC:CRLBF) are not permitted to deduct legitimate business expenses like marketing and advertising, health insurance premiums, interest, rent, or even employee salaries.</p>\n<p>Those deductions could be the difference between being profitable and running ruinous losses -- or for companies that do manage to turn a profit, from having additional resources to invest in their business.</p>\n<h2>Double jeopardy</h2>\n<p>The offending section of the tax code is Section 280e, which allows a cannabis business to deduct only the expenses directly related to sales of product, and not those associated with carrying on the actual business. So they're able to deduct the cost of goods sold, but not expenses related to selling, general, and administrative efforts.</p>\n<p>All this means a marijuana company is being taxed on its gross profits rather than operating income, which could make its effective tax rate well more than double a similarly structured business not in the cannabis industry. In short, marijuana companies might be taxed on more income than they actually make.</p>\n<p>Tim Winkler, controller at Ferro Cannabis, a Michigan-based cultivator of pot for medical and adult use, says the problem is more acute for dispensaries than for grow operations, but \"this is cash, so EBITDA [earnings before interest, taxes, depreciation, and amortization] takes the hit as well.\"</p>\n<p>EBITDA is a metric many investors use to compare businesses, as it largely focuses on how a company is operating, its profitability, and its cash flow. While not perfect, it serves as shorthand for investors evaluating a business -- and since marijuana companies are not able to deduct any of the listed expenses, they are put at a disadvantage. And obviously, the bigger the business, the bigger the hit it takes in taxes.</p>\n<h2>The high cost of success</h2>\n<p>All this is why many marijuana companies don't operate in the U.S. <b>Canopy Growth</b>, <b>HEXO</b>, <b>Tilray</b>, and others remain firmly ensconced in Canada so that they're not subject to Section 280e oversight.</p>\n<p>Meanwhile, some companies -- such as multistate dispensary operators like <b>Curaleaf Holdings</b> (OTC:CURLF), <b>Green Thumb Industries</b> (OTC:GTBIF), Trulieve, and <b>Harvest Health & Recreation </b>(OTC:HRVSF) (which Trulieve is acquiring) -- actually have it worse.</p>\n<p>Even though they're Canadian companies subject to Canadian taxes, because they operate state-level legal cannabis businesses in the U.S., they are taxed a second time as U.S. corporations. And in states that align their local tax codes with the IRS code, they can't deduct normal business expenses locally, either.</p>\n<p>The results are evident in their financial statements: As their business grows, their tax liability often increases exponentially.</p>\n<table>\n <thead>\n <tr>\n <th><p><b>Company</b></p></th>\n <th><p><b>2019-2020 Revenue Increase %</b></p></th>\n <th><p><b>2019-2020 Income Tax Provision Increase %</b></p></th>\n <th><p><b>No. of States Where It Operates</b></p></th>\n </tr>\n </thead>\n <tbody>\n <tr>\n <td><p>Cresco Labs</p></td>\n <td><p>292%</p></td>\n <td><p>232%</p></td>\n <td><p>18</p></td>\n </tr>\n <tr>\n <td><p>Curaleaf</p></td>\n <td><p>160%</p></td>\n <td><p>247%</p></td>\n <td><p>23</p></td>\n </tr>\n <tr>\n <td><p>Green Thumb Industries</p></td>\n <td><p>157%</p></td>\n <td><p>802%</p></td>\n <td><p>12</p></td>\n </tr>\n <tr>\n <td><p>Harvest Health</p></td>\n <td><p>98%</p></td>\n <td><p>230%</p></td>\n <td><p>5</p></td>\n </tr>\n <tr>\n <td><p>Trulieve</p></td>\n <td><p>106%</p></td>\n <td><p>87%</p></td>\n <td><p>6</p></td>\n </tr>\n </tbody>\n</table>\n<p>Data source: Company websites.</p>\n<h2>Paying their fair share</h2>\n<p>Federal legalization of marijuana would obviously eliminate the undue burden cannabis companies face when calculating their taxes, but as noted previously, it could unleash a regulatory burden that might be just as bad as the current system.</p>\n<p>There's a reason the black market in marijuana still proliferates even where states have legalized it: The government has made the cost of doing business too expensive, which shows up in prices. It's often just cheaper to buy illegal weed.</p>\n<p>It's a testament to their businesses that Cresco and Trulieve have been able to grow sales faster than their taxes, but if cannabis companies had their druthers, they might just prefer the government to enact tax reform over marijuana legalization.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Do Cannabis Stocks Need Tax Reform More Than Legalization?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDo Cannabis Stocks Need Tax Reform More Than Legalization?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 10:05 GMT+8 <a href=https://www.fool.com/investing/2021/06/28/do-cannabis-stocks-need-tax-reform-more-than-legal/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The patchwork, state-by-state legalization of marijuana in the U.S. has created a market for cannabis companies that is less than ideal, leaving many people hoping the federal government will finally ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/28/do-cannabis-stocks-need-tax-reform-more-than-legal/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TCNNF":"Trulieve Cannabis Corporation","CRLBF":"Cresco Labs Inc."},"source_url":"https://www.fool.com/investing/2021/06/28/do-cannabis-stocks-need-tax-reform-more-than-legal/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146831625","content_text":"The patchwork, state-by-state legalization of marijuana in the U.S. has created a market for cannabis companies that is less than ideal, leaving many people hoping the federal government will finally decriminalize pot, as Canada has.\nYet the rollout of legal weed north of the border has also been marked by bureaucratic bungling that has inhibited cannabis stocks from realizing their full potential. Legalizing marijuana at the federal level in the U.S. might create a regulatory burden that's even more prohibitive than what legal pot companies already experience from the individual states.\nWhat the marijuana industry might need more than legalization is tax reform, because the current code is at odds with how legal cannabis businesses operate -- and with common sense.\nCarrying a heavy burden\nTo prevent drug traffickers from profiting off their illegal activity, the federal government naturally prohibits them from taking tax deductions.\nWhile you wouldn't think that was necessary since what traffickers are doing is against the law, the tax court in the 1970s actually allowed a cocaine and amphetamines trafficker to deduct his \"business expenses,\" and Congress ended up enacting a law to prevent traffickers from doing that again.\nPeople don't consider their local marijuana dispensary owner to be anything like the guy hauling kilos of cocaine across the ocean in a cigarette boat and evading the Coast Guard. But because cannabis remains a Class I controlled dangerous substance, the Internal Revenue Service doesn't make any such distinctions.\nSo legal cannabis companies like Trulieve (OTC:TCNNF) and Cresco Labs (OTC:CRLBF) are not permitted to deduct legitimate business expenses like marketing and advertising, health insurance premiums, interest, rent, or even employee salaries.\nThose deductions could be the difference between being profitable and running ruinous losses -- or for companies that do manage to turn a profit, from having additional resources to invest in their business.\nDouble jeopardy\nThe offending section of the tax code is Section 280e, which allows a cannabis business to deduct only the expenses directly related to sales of product, and not those associated with carrying on the actual business. So they're able to deduct the cost of goods sold, but not expenses related to selling, general, and administrative efforts.\nAll this means a marijuana company is being taxed on its gross profits rather than operating income, which could make its effective tax rate well more than double a similarly structured business not in the cannabis industry. In short, marijuana companies might be taxed on more income than they actually make.\nTim Winkler, controller at Ferro Cannabis, a Michigan-based cultivator of pot for medical and adult use, says the problem is more acute for dispensaries than for grow operations, but \"this is cash, so EBITDA [earnings before interest, taxes, depreciation, and amortization] takes the hit as well.\"\nEBITDA is a metric many investors use to compare businesses, as it largely focuses on how a company is operating, its profitability, and its cash flow. While not perfect, it serves as shorthand for investors evaluating a business -- and since marijuana companies are not able to deduct any of the listed expenses, they are put at a disadvantage. And obviously, the bigger the business, the bigger the hit it takes in taxes.\nThe high cost of success\nAll this is why many marijuana companies don't operate in the U.S. Canopy Growth, HEXO, Tilray, and others remain firmly ensconced in Canada so that they're not subject to Section 280e oversight.\nMeanwhile, some companies -- such as multistate dispensary operators like Curaleaf Holdings (OTC:CURLF), Green Thumb Industries (OTC:GTBIF), Trulieve, and Harvest Health & Recreation (OTC:HRVSF) (which Trulieve is acquiring) -- actually have it worse.\nEven though they're Canadian companies subject to Canadian taxes, because they operate state-level legal cannabis businesses in the U.S., they are taxed a second time as U.S. corporations. And in states that align their local tax codes with the IRS code, they can't deduct normal business expenses locally, either.\nThe results are evident in their financial statements: As their business grows, their tax liability often increases exponentially.\n\n\n\nCompany\n2019-2020 Revenue Increase %\n2019-2020 Income Tax Provision Increase %\nNo. of States Where It Operates\n\n\n\n\nCresco Labs\n292%\n232%\n18\n\n\nCuraleaf\n160%\n247%\n23\n\n\nGreen Thumb Industries\n157%\n802%\n12\n\n\nHarvest Health\n98%\n230%\n5\n\n\nTrulieve\n106%\n87%\n6\n\n\n\nData source: Company websites.\nPaying their fair share\nFederal legalization of marijuana would obviously eliminate the undue burden cannabis companies face when calculating their taxes, but as noted previously, it could unleash a regulatory burden that might be just as bad as the current system.\nThere's a reason the black market in marijuana still proliferates even where states have legalized it: The government has made the cost of doing business too expensive, which shows up in prices. It's often just cheaper to buy illegal weed.\nIt's a testament to their businesses that Cresco and Trulieve have been able to grow sales faster than their taxes, but if cannabis companies had their druthers, they might just prefer the government to enact tax reform over marijuana legalization.","news_type":1},"isVote":1,"tweetType":1,"viewCount":408,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":162564219,"gmtCreate":1624068480031,"gmtModify":1703828073421,"author":{"id":"3582686134372532","authorId":"3582686134372532","name":"Leonardk","avatar":"https://static.tigerbbs.com/676f5d832122882228ccbdd0362da858","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582686134372532","authorIdStr":"3582686134372532"},"themes":[],"htmlText":"Hang in there","listText":"Hang in there","text":"Hang in there","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/162564219","repostId":"1166679093","repostType":4,"repost":{"id":"1166679093","pubTimestamp":1624065234,"share":"https://ttm.financial/m/news/1166679093?lang=&edition=fundamental","pubTime":"2021-06-19 09:13","market":"us","language":"en","title":"3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166679093","media":"fool","summary":"Meme stocks have been all the rage so far this year. That's understandable, with several of them del","content":"<p>Meme stocks have been all the rage so far this year. That's understandable, with several of them delivering triple-digit and even four-digit percentage gains.</p>\n<p>However, what goes up can come down. Analysts don't expect the online frenzy fueling the ginormous jumps for some of the most popular stocks will be sustainable. Here are three meme stocks that Wall Street thinks will plunge by more than 20% within the next 12 months.</p>\n<p>AMC Entertainment</p>\n<p><b>AMC Entertainment</b>(NYSE:AMC)ranks as the best-performing meme stock of all. Shares of the movie theater operator have skyrocketed close to 2,500% year to date.</p>\n<p>The consensus among analysts, though, is that the stock could lose 90% of its current value. Even the most optimistic analyst surveyed by Refinitiv has a price target for AMC that's more than 70% below the current share price.</p>\n<p>But isn't AMC's business picking up? Yep. The easing of restrictions has enabled the company to reopen 99% of its U.S. theaters. AMC could benefit as seating capacity limitations imposed by state and local governments are raised. Thereleases of multiple movies this summerand later this year that are likely to be hits should also help.</p>\n<p>However, Wall Street clearly believes that AMC's share price has gotten way ahead of its business prospects. The stock is trading at nearly eight times higher than it was before the COVID-19 pandemic.</p>\n<p>Clover Health Investments</p>\n<p>Only a few days ago, it looked like <b>Clover Health Investments</b>(NASDAQ:CLOV)might push AMC to the side as the hottest meme stock. Retail investors viewed Clover as a primeshort squeezecandidate.</p>\n<p>Since the beginning of June, shares of Clover Health have jumped more than 65%. Analysts, however, don't expect those gains to last. The average price target for the stock is 25% below the current share price.</p>\n<p>Clover Health's valuation does seem to have gotten out of hand. The healthcare stock currently trades at more than 170 times trailing-12-month sales. That's a nosebleed level, especially considering that the company is the subject of investigations by the U.S. Department of Justice and the Securities and Exchange Commission.</p>\n<p>Still, Clover Health could deliver improving financial results this year. The company hopes to significantly increase its membership by targeting the original Medicare program. This represents a major new market opportunity in addition to its current Medicare Advantage business.</p>\n<p>Sundial Growers</p>\n<p>At one point earlier this year, <b>Sundial Growers</b>(NASDAQ:SNDL)appeared to be a legitimate contender to become the biggest winner among meme stocks. The Canadian marijuana stock vaulted more than 520% higher year to date before giving up much of its gains. However, Sundial's share price has still more than doubled in 2021.</p>\n<p>Analysts anticipate that the pot stock could fall even further. The consensus price target for Sundial reflects a 23% discount to its current share price. One analyst even thinks the stock could sink 55%.</p>\n<p>There certainly are reasons to be pessimistic about Sundial's core cannabis business. The company's net cannabis revenue fell year over year in the first quarter of 2021. Although Sundial is taking steps that it hopes will turn things around, it remains to be seen if those efforts will succeed.</p>\n<p>Sundial's business deals could give investors reasons for optimism. After all, the company posted positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) in Q1 due to its investments.</p>\n<p>However, the cash that Sundial is using to make these investments has come at the cost of increased dilution of its stock. The company can't afford any additional dilution without having to resort to desperate measures to keep its listing on the <b>Nasdaq</b> stock exchange.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-19 09:13 GMT+8 <a href=https://www.fool.com/investing/2021/06/18/3-meme-stocks-wall-street-predicts-will-plunge-mor/><strong>fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Meme stocks have been all the rage so far this year. That's understandable, with several of them delivering triple-digit and even four-digit percentage gains.\nHowever, what goes up can come down. ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/18/3-meme-stocks-wall-street-predicts-will-plunge-mor/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线","SNDL":"SNDL Inc.","CLOV":"Clover Health Corp"},"source_url":"https://www.fool.com/investing/2021/06/18/3-meme-stocks-wall-street-predicts-will-plunge-mor/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166679093","content_text":"Meme stocks have been all the rage so far this year. That's understandable, with several of them delivering triple-digit and even four-digit percentage gains.\nHowever, what goes up can come down. Analysts don't expect the online frenzy fueling the ginormous jumps for some of the most popular stocks will be sustainable. Here are three meme stocks that Wall Street thinks will plunge by more than 20% within the next 12 months.\nAMC Entertainment\nAMC Entertainment(NYSE:AMC)ranks as the best-performing meme stock of all. Shares of the movie theater operator have skyrocketed close to 2,500% year to date.\nThe consensus among analysts, though, is that the stock could lose 90% of its current value. Even the most optimistic analyst surveyed by Refinitiv has a price target for AMC that's more than 70% below the current share price.\nBut isn't AMC's business picking up? Yep. The easing of restrictions has enabled the company to reopen 99% of its U.S. theaters. AMC could benefit as seating capacity limitations imposed by state and local governments are raised. Thereleases of multiple movies this summerand later this year that are likely to be hits should also help.\nHowever, Wall Street clearly believes that AMC's share price has gotten way ahead of its business prospects. The stock is trading at nearly eight times higher than it was before the COVID-19 pandemic.\nClover Health Investments\nOnly a few days ago, it looked like Clover Health Investments(NASDAQ:CLOV)might push AMC to the side as the hottest meme stock. Retail investors viewed Clover as a primeshort squeezecandidate.\nSince the beginning of June, shares of Clover Health have jumped more than 65%. Analysts, however, don't expect those gains to last. The average price target for the stock is 25% below the current share price.\nClover Health's valuation does seem to have gotten out of hand. The healthcare stock currently trades at more than 170 times trailing-12-month sales. That's a nosebleed level, especially considering that the company is the subject of investigations by the U.S. Department of Justice and the Securities and Exchange Commission.\nStill, Clover Health could deliver improving financial results this year. The company hopes to significantly increase its membership by targeting the original Medicare program. This represents a major new market opportunity in addition to its current Medicare Advantage business.\nSundial Growers\nAt one point earlier this year, Sundial Growers(NASDAQ:SNDL)appeared to be a legitimate contender to become the biggest winner among meme stocks. The Canadian marijuana stock vaulted more than 520% higher year to date before giving up much of its gains. However, Sundial's share price has still more than doubled in 2021.\nAnalysts anticipate that the pot stock could fall even further. The consensus price target for Sundial reflects a 23% discount to its current share price. One analyst even thinks the stock could sink 55%.\nThere certainly are reasons to be pessimistic about Sundial's core cannabis business. The company's net cannabis revenue fell year over year in the first quarter of 2021. Although Sundial is taking steps that it hopes will turn things around, it remains to be seen if those efforts will succeed.\nSundial's business deals could give investors reasons for optimism. After all, the company posted positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) in Q1 due to its investments.\nHowever, the cash that Sundial is using to make these investments has come at the cost of increased dilution of its stock. The company can't afford any additional dilution without having to resort to desperate measures to keep its listing on the Nasdaq stock exchange.","news_type":1},"isVote":1,"tweetType":1,"viewCount":788,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":802478837,"gmtCreate":1627800653029,"gmtModify":1703496089105,"author":{"id":"3582686134372532","authorId":"3582686134372532","name":"Leonardk","avatar":"https://static.tigerbbs.com/676f5d832122882228ccbdd0362da858","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582686134372532","authorIdStr":"3582686134372532"},"themes":[],"htmlText":"Please like","listText":"Please like","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/802478837","repostId":"1147877145","repostType":4,"repost":{"id":"1147877145","pubTimestamp":1627784916,"share":"https://ttm.financial/m/news/1147877145?lang=&edition=fundamental","pubTime":"2021-08-01 10:28","market":"us","language":"en","title":"Expect More Underwhelming Performance for SoFi Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1147877145","media":"InvestorPlace","summary":"The odds of a rapid rebound for fintech play SOFI stock appear dim.\n\nAsSoFiTechnologies(NASDAQ:SOFI)","content":"<blockquote>\n <b>The odds of a rapid rebound for fintech play SOFI stock appear dim.</b>\n</blockquote>\n<p>As<b>SoFiTechnologies</b>(NASDAQ:<b><u>SOFI</u></b>) stock falls back to around $15 per share, is now the time to buy? Not really. Over a long enough timeframe, entering a position in the fintech company’s shares right now could end up being a highly profitable move.</p>\n<p>Assuming of course, that it becomes the next<b>PayPal</b>(NASDAQ:<b><u>PYPL</u></b>) or<b>Square</b>(NYSE:<b><u>SQ</u></b>). Even so, that doesn’t mean there’s an urgent need to rush out and buy it today. More likely than not, the stock will deliver underwhelming returns in the months ahead.</p>\n<p>Why? The negative factors that have been weighing down on growth stocks. First, the risk that a hike in interest rates will result in avaluation contraction for richly priced namessuch as this one. Second, slowing economic growth could be another risk for shares. If today’s booming economy takes a breather, it may be tough for SoFi to deliver the blockbuster quarterly results investors expect from it.</p>\n<p>With the possibility of it languishing at $15 per share. Or worse yet, falling to $10 per share or less, the best move hasn’t changed in the past month. If you’re still bullish on it? Take your time when it comes to entering a position.</p>\n<p><b>SOFI Stock and Possible Further Downside</b></p>\n<p>After itsJune 1 deSPACing, SoFi shares seemed primed to make a comeback. Not only that, it seemed like the reputation of Chamath Palihapitiya, the sponsor of this former SPAC (special purpose acquisition company) was making a comeback as well.</p>\n<p>Yet, flash-forward around two months, and it seems like things are getting to where they were after last spring’s“SPAC Wipeout.”Investors haven’t shown much interest in Palihapitiya’slatest SPAC venture has been met with a yawn. Shares in his higher-profile holdings, like SOFI stock, along with<b>Clover Health</b>(NASDAQ:<b><u>CLOV</u></b>) stock have again lost their luster as well.</p>\n<p>SoFi has fallen back once again. But don’t assume it’s bottomed out. Not as much to do with any issues with the company itself. Instead, due to economy-wide factors that may result in it making another move to lower price levels. Again, as I’ve discussed previously, rising interest rates could have a big negative impact on its share price. Even as rising rates will be good for the company’s lending operations, this could be more than countered by valuation contraction.</p>\n<p>Giving things another look, it’s clear there’s another risk factor that could knock down the stock once again. That’s the potential for economic growth to start slowing down.</p>\n<p><b>High Valuation</b></p>\n<p>SOFI stock may be down big from its all-time high. But at today’s levels, it remains a “priced for perfection” situation. With projections calling for high double-digit growth, and recent results pointing to itbeating guidance, investors continue to have no trouble giving this stock a rich valuation.</p>\n<p>At $15 per share, shares trade for around 8.4x estimated 2022 revenues. Some, including<i>InvestorPlace’s</i>Larry Ramer, have questioned whether it makes sense to value this companymore like a tech firm than a bank. I also see this as an area of concern. Yet I don’t expect this factor alone to be what knocks it down to lower prices.</p>\n<p>What will? Again, it’s a sooner-than-expected rise in interest rates that could send shares down to even lower prices. But that’s not the only thing that could do so. Even if the Federal Reserve doesn’t turn on a dime, and shift from dovish to hawkish monetary policy, SOFI stock could find itself in trouble. How? If it starts delivering disappointing quarterly results.</p>\n<p>Sure, this may not happen in the immediate future. Yet, the above-average economic growth seen during the pandemic recovery/reopeningcould be running out of gas. If the economy starts to slow? It may get tougher for SoFi to live up to the high expectations currently priced into shares. Along with the valuation contraction risk, this is something else that could it down before it starts to rally once again.</p>\n<p><b>No Rush to Dive in at Today’s Prices</b></p>\n<p>Now may seem like an opportune time to scoop up SoFi shares on the cheap. But after selling off again, I wouldn’t expect any sort of rapid recovery. Just like a few weeks back, the risk of valuation contraction runs high. As more comes out of today’s still-booming economy could be set to slow down? The risk of underwhelming results in future quarters is starting to loom as well.</p>\n<p>So, with more negatives than positives, SOFI stock is likely to either going to trade sideways in the short term or worse, head down to lower prices. With this in mind, even investors who believe it’s a long-term winner shouldn’t hastily dive into it.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Expect More Underwhelming Performance for SoFi Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nExpect More Underwhelming Performance for SoFi Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-01 10:28 GMT+8 <a href=https://investorplace.com/2021/07/sofi-stock-expect-continued-underwhelming-performance/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The odds of a rapid rebound for fintech play SOFI stock appear dim.\n\nAsSoFiTechnologies(NASDAQ:SOFI) stock falls back to around $15 per share, is now the time to buy? Not really. Over a long enough ...</p>\n\n<a href=\"https://investorplace.com/2021/07/sofi-stock-expect-continued-underwhelming-performance/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SOFI":"SoFi Technologies Inc."},"source_url":"https://investorplace.com/2021/07/sofi-stock-expect-continued-underwhelming-performance/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147877145","content_text":"The odds of a rapid rebound for fintech play SOFI stock appear dim.\n\nAsSoFiTechnologies(NASDAQ:SOFI) stock falls back to around $15 per share, is now the time to buy? Not really. Over a long enough timeframe, entering a position in the fintech company’s shares right now could end up being a highly profitable move.\nAssuming of course, that it becomes the nextPayPal(NASDAQ:PYPL) orSquare(NYSE:SQ). Even so, that doesn’t mean there’s an urgent need to rush out and buy it today. More likely than not, the stock will deliver underwhelming returns in the months ahead.\nWhy? The negative factors that have been weighing down on growth stocks. First, the risk that a hike in interest rates will result in avaluation contraction for richly priced namessuch as this one. Second, slowing economic growth could be another risk for shares. If today’s booming economy takes a breather, it may be tough for SoFi to deliver the blockbuster quarterly results investors expect from it.\nWith the possibility of it languishing at $15 per share. Or worse yet, falling to $10 per share or less, the best move hasn’t changed in the past month. If you’re still bullish on it? Take your time when it comes to entering a position.\nSOFI Stock and Possible Further Downside\nAfter itsJune 1 deSPACing, SoFi shares seemed primed to make a comeback. Not only that, it seemed like the reputation of Chamath Palihapitiya, the sponsor of this former SPAC (special purpose acquisition company) was making a comeback as well.\nYet, flash-forward around two months, and it seems like things are getting to where they were after last spring’s“SPAC Wipeout.”Investors haven’t shown much interest in Palihapitiya’slatest SPAC venture has been met with a yawn. Shares in his higher-profile holdings, like SOFI stock, along withClover Health(NASDAQ:CLOV) stock have again lost their luster as well.\nSoFi has fallen back once again. But don’t assume it’s bottomed out. Not as much to do with any issues with the company itself. Instead, due to economy-wide factors that may result in it making another move to lower price levels. Again, as I’ve discussed previously, rising interest rates could have a big negative impact on its share price. Even as rising rates will be good for the company’s lending operations, this could be more than countered by valuation contraction.\nGiving things another look, it’s clear there’s another risk factor that could knock down the stock once again. That’s the potential for economic growth to start slowing down.\nHigh Valuation\nSOFI stock may be down big from its all-time high. But at today’s levels, it remains a “priced for perfection” situation. With projections calling for high double-digit growth, and recent results pointing to itbeating guidance, investors continue to have no trouble giving this stock a rich valuation.\nAt $15 per share, shares trade for around 8.4x estimated 2022 revenues. Some, includingInvestorPlace’sLarry Ramer, have questioned whether it makes sense to value this companymore like a tech firm than a bank. I also see this as an area of concern. Yet I don’t expect this factor alone to be what knocks it down to lower prices.\nWhat will? Again, it’s a sooner-than-expected rise in interest rates that could send shares down to even lower prices. But that’s not the only thing that could do so. Even if the Federal Reserve doesn’t turn on a dime, and shift from dovish to hawkish monetary policy, SOFI stock could find itself in trouble. How? If it starts delivering disappointing quarterly results.\nSure, this may not happen in the immediate future. Yet, the above-average economic growth seen during the pandemic recovery/reopeningcould be running out of gas. If the economy starts to slow? It may get tougher for SoFi to live up to the high expectations currently priced into shares. Along with the valuation contraction risk, this is something else that could it down before it starts to rally once again.\nNo Rush to Dive in at Today’s Prices\nNow may seem like an opportune time to scoop up SoFi shares on the cheap. But after selling off again, I wouldn’t expect any sort of rapid recovery. Just like a few weeks back, the risk of valuation contraction runs high. As more comes out of today’s still-booming economy could be set to slow down? The risk of underwhelming results in future quarters is starting to loom as well.\nSo, with more negatives than positives, SOFI stock is likely to either going to trade sideways in the short term or worse, head down to lower prices. With this in mind, even investors who believe it’s a long-term winner shouldn’t hastily dive into it.","news_type":1},"isVote":1,"tweetType":1,"viewCount":703,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159070617,"gmtCreate":1624933264939,"gmtModify":1703848268799,"author":{"id":"3582686134372532","authorId":"3582686134372532","name":"Leonardk","avatar":"https://static.tigerbbs.com/676f5d832122882228ccbdd0362da858","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582686134372532","authorIdStr":"3582686134372532"},"themes":[],"htmlText":"Up up up","listText":"Up up up","text":"Up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/159070617","repostId":"2146831625","repostType":4,"repost":{"id":"2146831625","pubTimestamp":1624932300,"share":"https://ttm.financial/m/news/2146831625?lang=&edition=fundamental","pubTime":"2021-06-29 10:05","market":"us","language":"en","title":"Do Cannabis Stocks Need Tax Reform More Than Legalization?","url":"https://stock-news.laohu8.com/highlight/detail?id=2146831625","media":"Motley Fool","summary":"Pot companies may do better dealing with a fairer tax code than navigating a regulatory labyrinth.","content":"<p>The patchwork, state-by-state legalization of marijuana in the U.S. has created a market for cannabis companies that is less than ideal, leaving many people hoping the federal government will finally decriminalize pot, as Canada has.</p>\n<p>Yet the rollout of legal weed north of the border has also been marked by bureaucratic bungling that has inhibited cannabis stocks from realizing their full potential. Legalizing marijuana at the federal level in the U.S. might create a regulatory burden that's even more prohibitive than what legal pot companies already experience from the individual states.</p>\n<p>What the marijuana industry might need more than legalization is tax reform, because the current code is at odds with how legal cannabis businesses operate -- and with common sense.</p>\n<h2>Carrying a heavy burden</h2>\n<p>To prevent drug traffickers from profiting off their illegal activity, the federal government naturally prohibits them from taking tax deductions.</p>\n<p>While you wouldn't think that was necessary since what traffickers are doing is against the law, the tax court in the 1970s actually allowed a cocaine and amphetamines trafficker to deduct his \"business expenses,\" and Congress ended up enacting a law to prevent traffickers from doing that again.</p>\n<p>People don't consider their local marijuana dispensary owner to be anything like the guy hauling kilos of cocaine across the ocean in a cigarette boat and evading the Coast Guard. But because cannabis remains a Class I controlled dangerous substance, the Internal Revenue Service doesn't make any such distinctions.</p>\n<p>So legal cannabis companies like <b>Trulieve</b> (OTC:TCNNF) and <b>Cresco Labs</b> (OTC:CRLBF) are not permitted to deduct legitimate business expenses like marketing and advertising, health insurance premiums, interest, rent, or even employee salaries.</p>\n<p>Those deductions could be the difference between being profitable and running ruinous losses -- or for companies that do manage to turn a profit, from having additional resources to invest in their business.</p>\n<h2>Double jeopardy</h2>\n<p>The offending section of the tax code is Section 280e, which allows a cannabis business to deduct only the expenses directly related to sales of product, and not those associated with carrying on the actual business. So they're able to deduct the cost of goods sold, but not expenses related to selling, general, and administrative efforts.</p>\n<p>All this means a marijuana company is being taxed on its gross profits rather than operating income, which could make its effective tax rate well more than double a similarly structured business not in the cannabis industry. In short, marijuana companies might be taxed on more income than they actually make.</p>\n<p>Tim Winkler, controller at Ferro Cannabis, a Michigan-based cultivator of pot for medical and adult use, says the problem is more acute for dispensaries than for grow operations, but \"this is cash, so EBITDA [earnings before interest, taxes, depreciation, and amortization] takes the hit as well.\"</p>\n<p>EBITDA is a metric many investors use to compare businesses, as it largely focuses on how a company is operating, its profitability, and its cash flow. While not perfect, it serves as shorthand for investors evaluating a business -- and since marijuana companies are not able to deduct any of the listed expenses, they are put at a disadvantage. And obviously, the bigger the business, the bigger the hit it takes in taxes.</p>\n<h2>The high cost of success</h2>\n<p>All this is why many marijuana companies don't operate in the U.S. <b>Canopy Growth</b>, <b>HEXO</b>, <b>Tilray</b>, and others remain firmly ensconced in Canada so that they're not subject to Section 280e oversight.</p>\n<p>Meanwhile, some companies -- such as multistate dispensary operators like <b>Curaleaf Holdings</b> (OTC:CURLF), <b>Green Thumb Industries</b> (OTC:GTBIF), Trulieve, and <b>Harvest Health & Recreation </b>(OTC:HRVSF) (which Trulieve is acquiring) -- actually have it worse.</p>\n<p>Even though they're Canadian companies subject to Canadian taxes, because they operate state-level legal cannabis businesses in the U.S., they are taxed a second time as U.S. corporations. And in states that align their local tax codes with the IRS code, they can't deduct normal business expenses locally, either.</p>\n<p>The results are evident in their financial statements: As their business grows, their tax liability often increases exponentially.</p>\n<table>\n <thead>\n <tr>\n <th><p><b>Company</b></p></th>\n <th><p><b>2019-2020 Revenue Increase %</b></p></th>\n <th><p><b>2019-2020 Income Tax Provision Increase %</b></p></th>\n <th><p><b>No. of States Where It Operates</b></p></th>\n </tr>\n </thead>\n <tbody>\n <tr>\n <td><p>Cresco Labs</p></td>\n <td><p>292%</p></td>\n <td><p>232%</p></td>\n <td><p>18</p></td>\n </tr>\n <tr>\n <td><p>Curaleaf</p></td>\n <td><p>160%</p></td>\n <td><p>247%</p></td>\n <td><p>23</p></td>\n </tr>\n <tr>\n <td><p>Green Thumb Industries</p></td>\n <td><p>157%</p></td>\n <td><p>802%</p></td>\n <td><p>12</p></td>\n </tr>\n <tr>\n <td><p>Harvest Health</p></td>\n <td><p>98%</p></td>\n <td><p>230%</p></td>\n <td><p>5</p></td>\n </tr>\n <tr>\n <td><p>Trulieve</p></td>\n <td><p>106%</p></td>\n <td><p>87%</p></td>\n <td><p>6</p></td>\n </tr>\n </tbody>\n</table>\n<p>Data source: Company websites.</p>\n<h2>Paying their fair share</h2>\n<p>Federal legalization of marijuana would obviously eliminate the undue burden cannabis companies face when calculating their taxes, but as noted previously, it could unleash a regulatory burden that might be just as bad as the current system.</p>\n<p>There's a reason the black market in marijuana still proliferates even where states have legalized it: The government has made the cost of doing business too expensive, which shows up in prices. It's often just cheaper to buy illegal weed.</p>\n<p>It's a testament to their businesses that Cresco and Trulieve have been able to grow sales faster than their taxes, but if cannabis companies had their druthers, they might just prefer the government to enact tax reform over marijuana legalization.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Do Cannabis Stocks Need Tax Reform More Than Legalization?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDo Cannabis Stocks Need Tax Reform More Than Legalization?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 10:05 GMT+8 <a href=https://www.fool.com/investing/2021/06/28/do-cannabis-stocks-need-tax-reform-more-than-legal/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The patchwork, state-by-state legalization of marijuana in the U.S. has created a market for cannabis companies that is less than ideal, leaving many people hoping the federal government will finally ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/28/do-cannabis-stocks-need-tax-reform-more-than-legal/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TCNNF":"Trulieve Cannabis Corporation","CRLBF":"Cresco Labs Inc."},"source_url":"https://www.fool.com/investing/2021/06/28/do-cannabis-stocks-need-tax-reform-more-than-legal/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146831625","content_text":"The patchwork, state-by-state legalization of marijuana in the U.S. has created a market for cannabis companies that is less than ideal, leaving many people hoping the federal government will finally decriminalize pot, as Canada has.\nYet the rollout of legal weed north of the border has also been marked by bureaucratic bungling that has inhibited cannabis stocks from realizing their full potential. Legalizing marijuana at the federal level in the U.S. might create a regulatory burden that's even more prohibitive than what legal pot companies already experience from the individual states.\nWhat the marijuana industry might need more than legalization is tax reform, because the current code is at odds with how legal cannabis businesses operate -- and with common sense.\nCarrying a heavy burden\nTo prevent drug traffickers from profiting off their illegal activity, the federal government naturally prohibits them from taking tax deductions.\nWhile you wouldn't think that was necessary since what traffickers are doing is against the law, the tax court in the 1970s actually allowed a cocaine and amphetamines trafficker to deduct his \"business expenses,\" and Congress ended up enacting a law to prevent traffickers from doing that again.\nPeople don't consider their local marijuana dispensary owner to be anything like the guy hauling kilos of cocaine across the ocean in a cigarette boat and evading the Coast Guard. But because cannabis remains a Class I controlled dangerous substance, the Internal Revenue Service doesn't make any such distinctions.\nSo legal cannabis companies like Trulieve (OTC:TCNNF) and Cresco Labs (OTC:CRLBF) are not permitted to deduct legitimate business expenses like marketing and advertising, health insurance premiums, interest, rent, or even employee salaries.\nThose deductions could be the difference between being profitable and running ruinous losses -- or for companies that do manage to turn a profit, from having additional resources to invest in their business.\nDouble jeopardy\nThe offending section of the tax code is Section 280e, which allows a cannabis business to deduct only the expenses directly related to sales of product, and not those associated with carrying on the actual business. So they're able to deduct the cost of goods sold, but not expenses related to selling, general, and administrative efforts.\nAll this means a marijuana company is being taxed on its gross profits rather than operating income, which could make its effective tax rate well more than double a similarly structured business not in the cannabis industry. In short, marijuana companies might be taxed on more income than they actually make.\nTim Winkler, controller at Ferro Cannabis, a Michigan-based cultivator of pot for medical and adult use, says the problem is more acute for dispensaries than for grow operations, but \"this is cash, so EBITDA [earnings before interest, taxes, depreciation, and amortization] takes the hit as well.\"\nEBITDA is a metric many investors use to compare businesses, as it largely focuses on how a company is operating, its profitability, and its cash flow. While not perfect, it serves as shorthand for investors evaluating a business -- and since marijuana companies are not able to deduct any of the listed expenses, they are put at a disadvantage. And obviously, the bigger the business, the bigger the hit it takes in taxes.\nThe high cost of success\nAll this is why many marijuana companies don't operate in the U.S. Canopy Growth, HEXO, Tilray, and others remain firmly ensconced in Canada so that they're not subject to Section 280e oversight.\nMeanwhile, some companies -- such as multistate dispensary operators like Curaleaf Holdings (OTC:CURLF), Green Thumb Industries (OTC:GTBIF), Trulieve, and Harvest Health & Recreation (OTC:HRVSF) (which Trulieve is acquiring) -- actually have it worse.\nEven though they're Canadian companies subject to Canadian taxes, because they operate state-level legal cannabis businesses in the U.S., they are taxed a second time as U.S. corporations. And in states that align their local tax codes with the IRS code, they can't deduct normal business expenses locally, either.\nThe results are evident in their financial statements: As their business grows, their tax liability often increases exponentially.\n\n\n\nCompany\n2019-2020 Revenue Increase %\n2019-2020 Income Tax Provision Increase %\nNo. of States Where It Operates\n\n\n\n\nCresco Labs\n292%\n232%\n18\n\n\nCuraleaf\n160%\n247%\n23\n\n\nGreen Thumb Industries\n157%\n802%\n12\n\n\nHarvest Health\n98%\n230%\n5\n\n\nTrulieve\n106%\n87%\n6\n\n\n\nData source: Company websites.\nPaying their fair share\nFederal legalization of marijuana would obviously eliminate the undue burden cannabis companies face when calculating their taxes, but as noted previously, it could unleash a regulatory burden that might be just as bad as the current system.\nThere's a reason the black market in marijuana still proliferates even where states have legalized it: The government has made the cost of doing business too expensive, which shows up in prices. It's often just cheaper to buy illegal weed.\nIt's a testament to their businesses that Cresco and Trulieve have been able to grow sales faster than their taxes, but if cannabis companies had their druthers, they might just prefer the government to enact tax reform over marijuana legalization.","news_type":1},"isVote":1,"tweetType":1,"viewCount":408,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":808363693,"gmtCreate":1627558001912,"gmtModify":1703492329751,"author":{"id":"3582686134372532","authorId":"3582686134372532","name":"Leonardk","avatar":"https://static.tigerbbs.com/676f5d832122882228ccbdd0362da858","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582686134372532","authorIdStr":"3582686134372532"},"themes":[],"htmlText":"Do we hold?","listText":"Do we hold?","text":"Do we hold?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/808363693","repostId":"1131779285","repostType":4,"repost":{"id":"1131779285","pubTimestamp":1627551074,"share":"https://ttm.financial/m/news/1131779285?lang=&edition=fundamental","pubTime":"2021-07-29 17:31","market":"us","language":"en","title":"AMD Is The New Bellwether","url":"https://stock-news.laohu8.com/highlight/detail?id=1131779285","media":"seekingalpha","summary":"Summary\n\nAMD's earnings report on Tuesday has pushed me over the edge as to where my money needs to ","content":"<p><b>Summary</b></p>\n<ul>\n <li>AMD's earnings report on Tuesday has pushed me over the edge as to where my money needs to be.</li>\n <li>The revenue growth and valuations prove the market wants one thing: Growth.</li>\n <li>Intel has lost the bellwether title as it grows below the industry and AMD grows above it.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8a41ea3a1a9c98364332ee70330427e8\" tg-width=\"1536\" tg-height=\"1024\" width=\"100%\" height=\"auto\"><span>nantonov/iStock Editorial via Getty Images</span></p>\n<p>It's hard to deny AMD (AMD) isn't the new up-and-coming bellwether of logic semiconductors, a position undoubtedly claimed by the chip king Intel (INTC). With AMD's latest earnings report on Tuesday, the title is no longer uncontested, even with the dramatic difference in absolute dollar figures between the two. One is growing big time while the other has been in a perpetual state of discord, in part or in whole, due to unresolved business direction. On Tuesday, AMD proved it isn't relenting any time soon in its pursuit of taking the semiconductor bellwether title. In fact, it may change the definition altogether as the growth it's producing in this sector is unheard of. It's time I give AMD the thumbs up and not just watch on the sidelines.</p>\n<p><b>Growth, Growth, Growth</b></p>\n<p>Much like the age-old adage for real estate of \"location, location, location\" to sell property, growth, growth, growth is the market's adage for share returns.</p>\n<p>The market is simple when it comes to tech and anything to do with it: It pays for growth, not indecision. AMD is growing, Intel is indecisive. And not just decision-making indecisive, I'm talking business execution indecisive. AMD is proving it can produce monstrous growth, and Intel is proving incremental growth is all it can do.</p>\n<p>The chart is simple. These are two very different companies:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/64f87e5b692256d2b0c4584ad37e8fdf\" tg-width=\"640\" tg-height=\"344\" width=\"100%\" height=\"auto\"><span>Chart mine, data from AMD and Intel earnings reports (non-GAAP for Intel)</span></p>\n<p>Both companies experienced a similar slowdown during the pandemic quarter of last year (Q2), but these two companies couldn't be any more different from there. While Intel struggled to find growth, especially in the data center division, AMD was stacking bills in all categories, including EPYC sales, except for a seasonal lull in semi-custom after a large gaming console launch.</p>\n<p>Since then, the story has been very dull for Intel, with flatlined or negative growth while AMD nearly doubled growth over the trough of the pandemic with its latest report.</p>\n<p>A slow down to 46%-50% in Q3 from 100% in Q2 and even from 55% to 50% year-over-year is to be expected as the great gaming console launch of 2020 will not repeat at the same level. But, to still guide for near 50% growth with that tough comp is what, in part, is driving my bullishness.</p>\n<p><b>The Valuation Proves It</b></p>\n<p>Now, of course, the market is in fact paying differently for both companies. The crucial difference is growth paves the way for better returns while stagnating growth paves the way for declines. The stock prices reflect as much:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2dad2d35040d78da964efd16dcb1a6c3\" tg-width=\"635\" tg-height=\"433\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p>\n<p>But the valuations also keep pace with the market's expectations:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bd156a2787d8c3774149c77bf71063b2\" tg-width=\"635\" tg-height=\"433\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p>\n<p><i>(AMD with Q2 and updated guidance should push the forward P/E to ~38)</i></p>\n<p>AMD's growth is worth (now) around 38 times earnings. But if you put the stock chart and the PE chart over each other, one continues to rise while the other continues to grow into it (compressing). On the other hand, Intel continues to meander as its valuation remains sideways and revenue continues to struggle, resulting in a diminishing stock return.</p>\n<p><b>The Bottom Line</b></p>\n<p>Intel bulls - you can say Intel has loads more cash flow and much higher revenue numbers (and it does), but the market isn't paying for that - clearly, as the stock price is stagnant over the last one-and-a-half years. The market is paying for growth. Period. Intel has very little to none, and AMD continues to prove it has it and more.</p>\n<p>You can be a fanboy of either company, but what good is being a fanboy if you're not getting a return on your cheerleading?</p>\n<p>One can continue to keep their money in Intel and collect 8%, including dividends, over two years, or carefully invest it in growth, which AMD is providing. This doesn't mean I love AMD's products - its graphics division leaves a lot to be desired (true ray tracing, DLSS 2.0, etc.) - but I can't stand by and hope Intel figures it out while AMD puts up the numbers it has been.</p>\n<p><b>The Bellwether Title Up For Grabs</b></p>\n<p>The basis for AMD taking over the bellwether position is because Intel can no longer provide the barometer for what the industry is doing. The semiconductor industry isn't shrinking. It's growing. From 2020 to 2021,the logic semiconductor industry is expected to grow 17% and over 6% from 2021 to 2022. Intel doesn't see that, it's below it. AMD doesn't see that, it's above it.</p>\n<p>I know which one is going to give me the heartbeat of the industry.</p>\n<p>You tell me which one is going to produce returns over the next year to two years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMD Is The New Bellwether</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMD Is The New Bellwether\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-29 17:31 GMT+8 <a href=https://seekingalpha.com/article/4442043-amd-is-the-new-bellwether><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nAMD's earnings report on Tuesday has pushed me over the edge as to where my money needs to be.\nThe revenue growth and valuations prove the market wants one thing: Growth.\nIntel has lost the ...</p>\n\n<a href=\"https://seekingalpha.com/article/4442043-amd-is-the-new-bellwether\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMD":"美国超微公司"},"source_url":"https://seekingalpha.com/article/4442043-amd-is-the-new-bellwether","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131779285","content_text":"Summary\n\nAMD's earnings report on Tuesday has pushed me over the edge as to where my money needs to be.\nThe revenue growth and valuations prove the market wants one thing: Growth.\nIntel has lost the bellwether title as it grows below the industry and AMD grows above it.\n\nnantonov/iStock Editorial via Getty Images\nIt's hard to deny AMD (AMD) isn't the new up-and-coming bellwether of logic semiconductors, a position undoubtedly claimed by the chip king Intel (INTC). With AMD's latest earnings report on Tuesday, the title is no longer uncontested, even with the dramatic difference in absolute dollar figures between the two. One is growing big time while the other has been in a perpetual state of discord, in part or in whole, due to unresolved business direction. On Tuesday, AMD proved it isn't relenting any time soon in its pursuit of taking the semiconductor bellwether title. In fact, it may change the definition altogether as the growth it's producing in this sector is unheard of. It's time I give AMD the thumbs up and not just watch on the sidelines.\nGrowth, Growth, Growth\nMuch like the age-old adage for real estate of \"location, location, location\" to sell property, growth, growth, growth is the market's adage for share returns.\nThe market is simple when it comes to tech and anything to do with it: It pays for growth, not indecision. AMD is growing, Intel is indecisive. And not just decision-making indecisive, I'm talking business execution indecisive. AMD is proving it can produce monstrous growth, and Intel is proving incremental growth is all it can do.\nThe chart is simple. These are two very different companies:\nChart mine, data from AMD and Intel earnings reports (non-GAAP for Intel)\nBoth companies experienced a similar slowdown during the pandemic quarter of last year (Q2), but these two companies couldn't be any more different from there. While Intel struggled to find growth, especially in the data center division, AMD was stacking bills in all categories, including EPYC sales, except for a seasonal lull in semi-custom after a large gaming console launch.\nSince then, the story has been very dull for Intel, with flatlined or negative growth while AMD nearly doubled growth over the trough of the pandemic with its latest report.\nA slow down to 46%-50% in Q3 from 100% in Q2 and even from 55% to 50% year-over-year is to be expected as the great gaming console launch of 2020 will not repeat at the same level. But, to still guide for near 50% growth with that tough comp is what, in part, is driving my bullishness.\nThe Valuation Proves It\nNow, of course, the market is in fact paying differently for both companies. The crucial difference is growth paves the way for better returns while stagnating growth paves the way for declines. The stock prices reflect as much:\nData by YCharts\nBut the valuations also keep pace with the market's expectations:\nData by YCharts\n(AMD with Q2 and updated guidance should push the forward P/E to ~38)\nAMD's growth is worth (now) around 38 times earnings. But if you put the stock chart and the PE chart over each other, one continues to rise while the other continues to grow into it (compressing). On the other hand, Intel continues to meander as its valuation remains sideways and revenue continues to struggle, resulting in a diminishing stock return.\nThe Bottom Line\nIntel bulls - you can say Intel has loads more cash flow and much higher revenue numbers (and it does), but the market isn't paying for that - clearly, as the stock price is stagnant over the last one-and-a-half years. The market is paying for growth. Period. Intel has very little to none, and AMD continues to prove it has it and more.\nYou can be a fanboy of either company, but what good is being a fanboy if you're not getting a return on your cheerleading?\nOne can continue to keep their money in Intel and collect 8%, including dividends, over two years, or carefully invest it in growth, which AMD is providing. This doesn't mean I love AMD's products - its graphics division leaves a lot to be desired (true ray tracing, DLSS 2.0, etc.) - but I can't stand by and hope Intel figures it out while AMD puts up the numbers it has been.\nThe Bellwether Title Up For Grabs\nThe basis for AMD taking over the bellwether position is because Intel can no longer provide the barometer for what the industry is doing. The semiconductor industry isn't shrinking. It's growing. From 2020 to 2021,the logic semiconductor industry is expected to grow 17% and over 6% from 2021 to 2022. Intel doesn't see that, it's below it. AMD doesn't see that, it's above it.\nI know which one is going to give me the heartbeat of the industry.\nYou tell me which one is going to produce returns over the next year to two years.","news_type":1},"isVote":1,"tweetType":1,"viewCount":356,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":162564219,"gmtCreate":1624068480031,"gmtModify":1703828073421,"author":{"id":"3582686134372532","authorId":"3582686134372532","name":"Leonardk","avatar":"https://static.tigerbbs.com/676f5d832122882228ccbdd0362da858","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582686134372532","authorIdStr":"3582686134372532"},"themes":[],"htmlText":"Hang in there","listText":"Hang in there","text":"Hang in there","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/162564219","repostId":"1166679093","repostType":4,"repost":{"id":"1166679093","pubTimestamp":1624065234,"share":"https://ttm.financial/m/news/1166679093?lang=&edition=fundamental","pubTime":"2021-06-19 09:13","market":"us","language":"en","title":"3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166679093","media":"fool","summary":"Meme stocks have been all the rage so far this year. That's understandable, with several of them del","content":"<p>Meme stocks have been all the rage so far this year. That's understandable, with several of them delivering triple-digit and even four-digit percentage gains.</p>\n<p>However, what goes up can come down. Analysts don't expect the online frenzy fueling the ginormous jumps for some of the most popular stocks will be sustainable. Here are three meme stocks that Wall Street thinks will plunge by more than 20% within the next 12 months.</p>\n<p>AMC Entertainment</p>\n<p><b>AMC Entertainment</b>(NYSE:AMC)ranks as the best-performing meme stock of all. Shares of the movie theater operator have skyrocketed close to 2,500% year to date.</p>\n<p>The consensus among analysts, though, is that the stock could lose 90% of its current value. Even the most optimistic analyst surveyed by Refinitiv has a price target for AMC that's more than 70% below the current share price.</p>\n<p>But isn't AMC's business picking up? Yep. The easing of restrictions has enabled the company to reopen 99% of its U.S. theaters. AMC could benefit as seating capacity limitations imposed by state and local governments are raised. Thereleases of multiple movies this summerand later this year that are likely to be hits should also help.</p>\n<p>However, Wall Street clearly believes that AMC's share price has gotten way ahead of its business prospects. The stock is trading at nearly eight times higher than it was before the COVID-19 pandemic.</p>\n<p>Clover Health Investments</p>\n<p>Only a few days ago, it looked like <b>Clover Health Investments</b>(NASDAQ:CLOV)might push AMC to the side as the hottest meme stock. Retail investors viewed Clover as a primeshort squeezecandidate.</p>\n<p>Since the beginning of June, shares of Clover Health have jumped more than 65%. Analysts, however, don't expect those gains to last. The average price target for the stock is 25% below the current share price.</p>\n<p>Clover Health's valuation does seem to have gotten out of hand. The healthcare stock currently trades at more than 170 times trailing-12-month sales. That's a nosebleed level, especially considering that the company is the subject of investigations by the U.S. Department of Justice and the Securities and Exchange Commission.</p>\n<p>Still, Clover Health could deliver improving financial results this year. The company hopes to significantly increase its membership by targeting the original Medicare program. This represents a major new market opportunity in addition to its current Medicare Advantage business.</p>\n<p>Sundial Growers</p>\n<p>At one point earlier this year, <b>Sundial Growers</b>(NASDAQ:SNDL)appeared to be a legitimate contender to become the biggest winner among meme stocks. The Canadian marijuana stock vaulted more than 520% higher year to date before giving up much of its gains. However, Sundial's share price has still more than doubled in 2021.</p>\n<p>Analysts anticipate that the pot stock could fall even further. The consensus price target for Sundial reflects a 23% discount to its current share price. One analyst even thinks the stock could sink 55%.</p>\n<p>There certainly are reasons to be pessimistic about Sundial's core cannabis business. The company's net cannabis revenue fell year over year in the first quarter of 2021. Although Sundial is taking steps that it hopes will turn things around, it remains to be seen if those efforts will succeed.</p>\n<p>Sundial's business deals could give investors reasons for optimism. After all, the company posted positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) in Q1 due to its investments.</p>\n<p>However, the cash that Sundial is using to make these investments has come at the cost of increased dilution of its stock. The company can't afford any additional dilution without having to resort to desperate measures to keep its listing on the <b>Nasdaq</b> stock exchange.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-19 09:13 GMT+8 <a href=https://www.fool.com/investing/2021/06/18/3-meme-stocks-wall-street-predicts-will-plunge-mor/><strong>fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Meme stocks have been all the rage so far this year. That's understandable, with several of them delivering triple-digit and even four-digit percentage gains.\nHowever, what goes up can come down. ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/18/3-meme-stocks-wall-street-predicts-will-plunge-mor/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线","SNDL":"SNDL Inc.","CLOV":"Clover Health Corp"},"source_url":"https://www.fool.com/investing/2021/06/18/3-meme-stocks-wall-street-predicts-will-plunge-mor/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166679093","content_text":"Meme stocks have been all the rage so far this year. That's understandable, with several of them delivering triple-digit and even four-digit percentage gains.\nHowever, what goes up can come down. Analysts don't expect the online frenzy fueling the ginormous jumps for some of the most popular stocks will be sustainable. Here are three meme stocks that Wall Street thinks will plunge by more than 20% within the next 12 months.\nAMC Entertainment\nAMC Entertainment(NYSE:AMC)ranks as the best-performing meme stock of all. Shares of the movie theater operator have skyrocketed close to 2,500% year to date.\nThe consensus among analysts, though, is that the stock could lose 90% of its current value. Even the most optimistic analyst surveyed by Refinitiv has a price target for AMC that's more than 70% below the current share price.\nBut isn't AMC's business picking up? Yep. The easing of restrictions has enabled the company to reopen 99% of its U.S. theaters. AMC could benefit as seating capacity limitations imposed by state and local governments are raised. Thereleases of multiple movies this summerand later this year that are likely to be hits should also help.\nHowever, Wall Street clearly believes that AMC's share price has gotten way ahead of its business prospects. The stock is trading at nearly eight times higher than it was before the COVID-19 pandemic.\nClover Health Investments\nOnly a few days ago, it looked like Clover Health Investments(NASDAQ:CLOV)might push AMC to the side as the hottest meme stock. Retail investors viewed Clover as a primeshort squeezecandidate.\nSince the beginning of June, shares of Clover Health have jumped more than 65%. Analysts, however, don't expect those gains to last. The average price target for the stock is 25% below the current share price.\nClover Health's valuation does seem to have gotten out of hand. The healthcare stock currently trades at more than 170 times trailing-12-month sales. That's a nosebleed level, especially considering that the company is the subject of investigations by the U.S. Department of Justice and the Securities and Exchange Commission.\nStill, Clover Health could deliver improving financial results this year. The company hopes to significantly increase its membership by targeting the original Medicare program. This represents a major new market opportunity in addition to its current Medicare Advantage business.\nSundial Growers\nAt one point earlier this year, Sundial Growers(NASDAQ:SNDL)appeared to be a legitimate contender to become the biggest winner among meme stocks. The Canadian marijuana stock vaulted more than 520% higher year to date before giving up much of its gains. However, Sundial's share price has still more than doubled in 2021.\nAnalysts anticipate that the pot stock could fall even further. The consensus price target for Sundial reflects a 23% discount to its current share price. One analyst even thinks the stock could sink 55%.\nThere certainly are reasons to be pessimistic about Sundial's core cannabis business. The company's net cannabis revenue fell year over year in the first quarter of 2021. Although Sundial is taking steps that it hopes will turn things around, it remains to be seen if those efforts will succeed.\nSundial's business deals could give investors reasons for optimism. After all, the company posted positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) in Q1 due to its investments.\nHowever, the cash that Sundial is using to make these investments has come at the cost of increased dilution of its stock. The company can't afford any additional dilution without having to resort to desperate measures to keep its listing on the Nasdaq stock exchange.","news_type":1},"isVote":1,"tweetType":1,"viewCount":788,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
